Novartis AG Reversal Of Inventory Writedown
Novartis AG (NVS) reported Reversal Of Inventory Writedown of $160.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes › Inventory
ifrs-full:ReversalOfInventoryWritedown · last filed 2026-02-04
| Period end | Reversal Of Inventory Writedown 12 month | Reversal Of Inventory Writedown 12 month as first filed |
|---|---|---|
| 2025-12-31 | $160.00M 20-F · filed 2026-02-04 | |
| 2024-12-31 | $156.00M 20-F · filed 2026-02-04 | |
| 2023-12-31 | $111.00M 20-F · filed 2026-02-04 | |
| 2022-12-31 | $121.00M 20-F · filed 2025-01-31 | $161.00M 20-F · filed 2023-02-01 |
| 2021-12-31 | $97.00M 20-F · filed 2024-01-31 | $158.00M 20-F · filed 2022-02-02 |
| 2020-12-31 | $255.00M 20-F/A · filed 2023-05-15 | |
| 2019-12-31 | $218.00M 20-F · filed 2022-02-02 | |
| 2018-12-31 | $216.00M 20-F · filed 2021-01-26 | $272.00M 20-F · filed 2019-01-30 |
| 2017-12-31 | $172.00M 20-F · filed 2020-01-29 | $189.00M 6-K · filed 2018-01-24 |
| 2016-12-31 | $67.00M 20-F · filed 2019-01-30 | |
| 2015-12-31 | $148.00M 6-K · filed 2018-01-24 |